BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17109182)

  • 21. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial infections, immunomodulation, and drugs of abuse.
    Friedman H; Newton C; Klein TW
    Clin Microbiol Rev; 2003 Apr; 16(2):209-19. PubMed ID: 12692094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction: illicit drugs in Central Asia.
    Latypov A
    Int J Drug Policy; 2014 Nov; 25(6):1154. PubMed ID: 25223246
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV infection in injecting drug users.
    Durante A
    AIDS Care; 1991; 3(4):439-41. PubMed ID: 1786279
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
    Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
    Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing problems in diagnosing HTLV infection among intravenous drug users with AIDS in São Paulo City, Brazil.
    Casseb J; Souza T; Pierre-Lima MT; Yeh E; Hendry RM; Gallo D
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1639-41. PubMed ID: 9430256
    [No Abstract]   [Full Text] [Related]  

  • 28. Challenges in the development of an HIV-1 vaccine.
    Barouch DH
    Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug injecting and HIV infection among the population of drug abusers in Asia.
    Poshyachinda V
    Bull Narc; 1993; 45(1):77-90. PubMed ID: 8305908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streets, drugs, and the economy of sex in the age of AIDS.
    Weeks MR; Grier M; Romero-Daza N; Puglisi-Vasquez MJ; Singer M
    Women Health; 1998; 27(1-2):205-29. PubMed ID: 9640643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current problems in the morphological diagnosis of somatic disorders in drug addictions].
    Sherstiuk BV; Pigolkin IuI
    Sud Med Ekspert; 1999; 42(2):29-32. PubMed ID: 10224926
    [No Abstract]   [Full Text] [Related]  

  • 33. Shooting up: the interface of microbial infections and drug abuse.
    Kaushik KS; Kapila K; Praharaj AK
    J Med Microbiol; 2011 Apr; 60(Pt 4):408-422. PubMed ID: 21389334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is inhalant use a risk factor for heroin and injection drug use among adolescents in the United States?
    Wu LT; Howard MO
    Addict Behav; 2007 Feb; 32(2):265-81. PubMed ID: 16713124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.
    Vlahov D
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S3-6. PubMed ID: 7865324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccines for HIV: challenges and opportunities.
    Hokey DA; Weiner DB
    Springer Semin Immunopathol; 2006 Nov; 28(3):267-79. PubMed ID: 17031649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broadening inclusion of vulnerable populations in HIV vaccine trials.
    Lau CY; Cardinali M; Sato PA; Fix A; Flores J
    Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization.
    Migasena S; Suntharasamai P; Pitisuttithum P; Kitayaporn D; Wasi C; Huang W; Vanichseni S; Koompong C; Kaewkungwal J; Raktham S; Ippolito T; Hanson C; Gregory T; Heyward WL; Berman P; Francis D
    AIDS Res Hum Retroviruses; 2000 May; 16(7):655-63. PubMed ID: 10791876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination.
    Young AM; Halgin DS; Havens JR
    AIDS Care; 2015; 27(8):1000-4. PubMed ID: 25730519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tobacco use and illicit substance use disorders: what should we have to do?].
    Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
    Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.